| Line Item | 2024-04-26 | Y/Y |
|---|---|---|
| Revenue | $32.36B | +3.6% |
| Cost of Revenue | $11.22B | +4.6% |
| R&D Expense | $2.73B | +1.4% |
| SG&A Expense | $10.74B | +3.1% |
| Operating Income | $5.14B | -6.2% |
| Interest Expense | $719.0M | +13.1% |
| Pre-tax Income | $4.84B | -9.8% |
| Income Tax | $1.13B | -28.3% |
| Net Income | $3.68B |
| Line Item | 2024-04-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.28B | -16.8% |
| Short-term Investments | $6.72B | +4.8% |
| Accounts Receivable | $6.13B | +2.2% |
| Inventory | $5.22B | -1.4% |
| Current Assets | $21.93B | +1.2% |
| Total Assets | $89.98B | -1.1% |
| Current Liabilities | $10.79B | +19.2% |
| Line Item | 2024-04-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.79B | +12.4% |
| Capital Expenditures | $1.59B | +8.8% |
| Investing Cash Flow | -$2.37B | +32.3% |
| Financing Cash Flow | -$4.45B | +10.3% |
| Free Cash Flow | $5.20B | +13.5% |
| -2.2% |
| EPS (Basic) | $2.77 | -2.1% |
| EPS (Diluted) | $2.76 | -2.1% |
| Long-term Debt |
| $23.93B |
| -1.7% |
| Total Liabilities | $39.56B | +0.7% |
| Stockholders' Equity | $50.21B | -2.5% |